With only one holder of record and SEC reporting suspended, the stock will likely be delisted from Nasdaq and move to the OTC markets with minimal liquidity. Existing shareholders should expect no further public disclosures. Monitor for any subsequent going-private transaction filings or a potential squeeze-out of minority holders.
Price Chart
Executive Summary
KalVista Pharmaceuticals filed a Form 15-12G to terminate its SEC registration under Section 12(g), effective June 22, 2026. The filing states there is only one holder of record, indicating the company has gone private or been acquired, and will cease all SEC reporting obligations. This is a significant event that eliminates public transparency and liquidity for any remaining public shareholders.
Key Facts
- Filed Form 15-12G to terminate registration under Section 12(g) of the Securities Exchange Act of 1934
- Effective date: June 22, 2026
- Approximate number of holders of record as of certification date: One holder
- Company will suspend duty to file reports under Sections 13 and 15(d)
- Signed by John Hess, Chairman of the Board, President, and General Manager
- Formerly known as Carbylan Therapeutics, Inc. (name change in 2014)
Financial Impact
No financial figures provided in filing; the company is deregistering with only one holder of record, implying a going-private transaction or acquisition has occurred.
Risk Factors
- Complete loss of public market liquidity and price discovery
- No ongoing SEC reporting means no financial transparency for remaining shareholders
- Potential for a below-market squeeze-out or freeze-out merger at an unfavorable price
- Delisting from Nasdaq likely, moving to OTC Pink Sheets with limited trading
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001140361-26-025858 |
| Document: 0001140361-26-025858-index-headers.html | 0001140361-26-025858 |
| Document: 0001140361-26-025858-index.html | 0001140361-26-025858 |
| Document: 0001140361-26-025858.txt | 0001140361-26-025858 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 22, 2026 14w ago | 15-12G | โ | awaiting T+1 | โ | โ |
Jun 17, 2026 15w ago | EFFECT | $27.00 awaiting T+1 | awaiting T+1 | โ | โ |
Jun 11, 2026 16w ago | 8-K | $26.99 awaiting T+1 | awaiting T+1 | โ | โ |
Jun 11, 2026 16w ago | Institutional Cluster | $27.00 $27.00 | ยท 0.00% | โผ โ0.54% | โ |
May 19, 2026 19w ago | Insider Cluster | $26.81 $26.77 | โฒ +0.15% | โฒ +0.34% | โ |
May 19, 2026 19w ago | Insider Cluster | $26.81 $26.77 | โผ โ0.15% | โผ โ0.34% | โ |
Apr 29, 2026 22w ago | 8-K | $26.67 $26.66 | โผ โ0.04% | โผ โ1.06% | โ |
Apr 17, 2026 24w ago | Insider Cluster | $20.48 $20.87 | โผ โ1.90% | โผ โ2.10% | โ |
Feb 23, 2026 31w ago | Insider Cluster | $15.56 $15.77 | โผ โ1.35% | โผ โ0.61% | โ |
Feb 23, 2026 31w ago | Insider Cluster | $15.56 $15.77 | โผ โ1.35% | โผ โ0.61% | โ |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access